PMA supplement
P070006 S023: T-SPOT.TB Test
FDA PMA supplement · Real-Time Process · Oxford Immunotec, Ltd.
Key facts
| Original PMA | P070006 |
|---|---|
| Supplement number | S023 |
| Supplement type | Real-Time Process |
| Reason for the supplement | Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| Trade name | T-SPOT.TB Test |
| Generic name | Mycobacterium tuberculosis, Cell mediated immune response, enzyme-linked immunospot test |
| Applicant | Oxford Immunotec, Ltd. |
| Product code | OJN |
| Received date | Mar 6, 2024 |
| Decision date | Jun 4, 2024 |
At a glance
- No Expedited review granted
- No Approval order on file
- No Summary of safety and effectiveness on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA supplements
A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: